Table 2.
Laboratory data before the prescription of phosphate binders.
| LC (n = 19) | FCH (n = 27) | SFOH (n = 25) | p-value | |
|---|---|---|---|---|
| Hemoglobin (g/dl) | 11.4 ± 0.7 | 11.1 ± 0.8 | 11.1 ± 0.6 | 0.279a |
| Albumin (g/dl) | 3.6 (3.5–3.8) | 3.7 (3.5–3.8) | 3.6 (3.3–3.7) | 0.825b |
| Urea nitrogen (mg/dl) | 73 ± 12 | 63 ± 12 | 71 ± 14 | 0.030a |
| Creatinine (mg/dl) | 11.0 ± 2.5 | 12.2 ± 2.7 | 11.2 ± 2.7 | 0.225a |
| Calcium (mg/dl) | 8.8 ± 0.6 | 8.9 ± 0.5 | 8.7 ± 0.6 | 0.537a |
| Phosphate (mg/dl) | 6.5 ± 0.9 | 6.7 ± 1.1 | 6.7 ± 0.7 | 0.755a |
| Parathyroid hormone (pg/ml) | 268 (192–337) | 207 (141–268) | 288 (195–447) | 0.097b |
| Phosphate, average (mg/dl) | 5.9 ± 0.7 | 5.9 ± 0.7 | 6.2 ± 0.5 | 0.199a |
Uncorrected serum calcium levels are shown. The phosphate average means the average of pre-dialysis serum phosphate levels during 3 months before the prescription of the phosphate binder.
aOne-way ANOVA with a post-hoc Fisher’s protected least significant difference test.
bKruskal–Wallis one-way ANOVA on Ranks test.